Juvenile myoclonic epilepsy as a spectrum disorder: A focused review.
Baykan B, Wolf P.
Seizure. 2017 Jul;49:36-41. doi: 10.1016/j.seizure.2017.05.011. Epub 2017 May 18.
Juvenile Myoclonic Epilepsy.
Amrutkar CV, Riel-Romero RM.
2023 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME).
Fayad C, Saad K, Kahwagi GJ, Hallit S, Griffin D, Abou-Khalil R, El-Hayek E.
PLoS One. 2024 Apr 9;19(4):e0300930. doi: 10.1371/journal.pone.0300930. eCollection 2024.
Seizure and social outcomes in patients with juvenile myoclonic epilepsy (JME).
Asadi-Pooya AA, Rostamihosseinkhani M, Farazdaghi M.
Seizure. 2022 Apr;97:15-19. doi: 10.1016/j.seizure.2022.03.002. Epub 2022 Mar 3.
Juvenile myoclonic epilepsy.
Alfradique I, Vasconcelos MM.
Arq Neuropsiquiatr. 2007 Dec;65(4B):1266-71. doi: 10.1590/s0004-282x2007000700036.
Juvenile myoclonic epilepsy and sleep.
Xu L, Guo D, Liu YY, Qiao DD, Ye JY, Xue R.
Epilepsy Behav. 2018 Mar;80:326-330. doi: 10.1016/j.yebeh.2017.11.008. Epub 2018 Jan 19.
Juvenile myoclonic epilepsy--neuroimaging findings.
Koepp MJ, Woermann F, Savic I, Wandschneider B.
Epilepsy Behav. 2013 Jul;28 Suppl 1:S40-4. doi: 10.1016/j.yebeh.2012.06.035.
[Juvenile myoclonic epilepsy].
Syvertsen MR, Markhus R, Selmer KK, Nakken KO.
Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1610-3. doi: 10.4045/tidsskr.11.1518.
Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
Pietrafusa N, La Neve A, de Palma L, Boero G, Luisi C, Vigevano F, Specchio N.
Brain Dev. 2021 Jun;43(6):688-697. doi: 10.1016/j.braindev.2021.02.005. Epub 2021 Mar 27.
Juvenile Myoclonic Epilepsy (JME): Neuropsychological Profile and Related Factors with Cognitive Dysfunction.
Motamedi M, Nasergivehch S, Karamghadiri N, Noroozian M.
Iran J Psychiatry. 2014 Mar;9(1):14-9.
